Show
Sort by
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
-
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial
-
- Journal Article
- A1
- open access
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
-
- Journal Article
- A1
- open access
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
-
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial
-
- Journal Article
- A1
- open access
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
-
Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect